EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Results of GC – MS Analyses of 40 Extracts of Diabetes Devices

Emma M van Oers, Anton C de Groot iD, Patrick Verolme, Norbertus A Ipenburg iD, Thomas Rustemeyer iD

Contact Dermatitis · 2026-03 · 94 (3) · 234-244

DOI: 10.1111/cod.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contact Dermatitis, online erschienen am 28.11.2025. Verfasst von Emma M van Oers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Centers, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Allergens, Insulin Infusion Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Diabetes Research Foundation, Diabetes Fonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnostic patch testing in patients with suspected allergic Contact Dermatitis from glucose sensors, insulin pumps, and infusion sets is seriously hampered by a lack of information on the chemical composition of these diabetes devices.

Objectives

To identify the chemicals present in diabetes devices. Materials and Methods Forty acetone extracts of 27 devices (10 sensors, 3 patch pumps, 12 infusion sets and 2 single adhesives) were investigated by gas chromatography—mass spectrometry.

Results

Two hundred eighty four individual chemicals were identified. All 40 extracts contained one or more chemicals that were previously identified as allergens in diabetes devices causing allergic Contact Dermatitis. Fourteen of 27 devices (52%) contained one or more acrylates, 8 (30%) colophonium derivatives, all 27 (100%) one or two phenolic allergens (2,4‐di‐ tert ‐butylphenol, p ‐ tert‐ butylphenol, butylated hydroxytoluene), and 9 (33%) 1‐hydroxycyclohexyl phenyl ketone. None of the other chemicals were well‐known haptens, with the exception of bisphenol A, which was present in half of the extracts, in some cases in very high concentrations.

Conclusions

All products investigated contained chemicals already known to be sensitizers in diabetes devices. The data can help determine the relevance of positive patch tests, facilitate targeted patch testing with potential allergens and aid in advising safer alternatives for sensitized patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactAllergensInsulin Infusion SystemsGas Chromatography-Mass SpectrometryHumansPatch TestsBlood Glucose Self-MonitoringPhenolsAcrylatesAdhesives

Stichwörter der Autor:innen

GC–MSacrylatesallergenscolophoniumdiabetes devicesgas chromatography—mass spectrometryglucose sensorinsulin pumpisocyanatesphenolic chemicals

Substanzen

AllergensPhenolsAcrylatesAdhesives

Autor:innen und Institutionen

  • Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • NEDLAB, Middelharnis, the Netherlands.

ORCID-Profile: Anton C de Groot, Norbertus A Ipenburg, Thomas Rustemeyer

Förderung

  • Dutch Diabetes Research Foundation
  • Diabetes Fonds

Zitieren

APA

van Oers, E. M., de Groot, A. C., Verolme, P., Ipenburg, N. A., & Rustemeyer, T. (2026). Results of GC – MS Analyses of 40 Extracts of Diabetes Devices. Contact Dermatitis, 94(3), 234-244. https://doi.org/10.1111/cod.70052

Vancouver

van Oers EM, de Groot AC, Verolme P, Ipenburg NA, Rustemeyer T. Results of GC – MS Analyses of 40 Extracts of Diabetes Devices. Contact Dermatitis. 2026;94(3):234-244. doi:10.1111/cod.70052

BibTeX
@article{vanOers2026,
  author = {van Oers, Emma M and de Groot, Anton C and Verolme, Patrick and Ipenburg, Norbertus A and Rustemeyer, Thomas},
  title = {Results of GC – MS Analyses of 40 Extracts of Diabetes Devices},
  journal = {Contact Dermatitis},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {234--244},
  doi = {10.1111/cod.70052}
}
Kostenlos starten →